Imo I'm wondering what they are showcasing here and with the other presentation is when LL was involved in combination with other treatments after other failed treatments, it produced a certain percentage of remission in patients--not just longer survival time...remission.
Hopefully this catches the attention of some doctors treating those with colon cancer to look into. Who knows it might help our enrollment.
Imo
(4)
(0)
CytoDyn Inc (CYDY) Stock Research Links
The fault-finder will find faults even in paradise. -Henry David Thoreau